Dysregulated Circulating MiR-4429 Serves As a Novel Non-Invasive Biomarker and Is Correlated With EGFR Mutation in Patients With Non-Small Cell Lung Cancer. Biomol Biomed 2022, 22 (4), 553-559. https://doi.org/10.17305/bjbms.2021.6450.